World's biggest heart model simulated at Université de Mon...(the electrical triggers of the various k...)
Navigation Links
World's biggest heart model simulated at Université de Montréal
Date:1/18/2008
the electrical triggers of the various kinds of heart disease could lead to earlier diagnosis and new treatment breakthroughs. In order to understand what the mechanisms of the particular disease are, the heart must be modeled with enormous detail. Once disease mechanisms are fully understood, scientists will be able to devise the best drug or the best cure surgical or other remedies -- and doctors will be able to diagnose much more precisely. Without the use of computer models it can be hard to track the effects of a heart disease on the ECG.
'/>"/>
| Contact: S-J Desjardins sylvain-jacques.desjardins@umontreal.ca 514-343-7593 University of Montreal Source:Eurekalert |
Related biology news :
1. The best both of worlds -- how to have sex and survive
2. 390-million-year-old scorpion fossil -- biggest bug known
3. Abnormal fat metabolism underlies heart problems in diabetic patients
4. High blood pressure, low energy -- a recipe for heart failure
5. Human derived stem cells can repair rat hearts damaged by heart attack
6. Geron Demonstrates hESC-derived cardiomyocytes improve heart function after myocardial infarction
7. Heart of Herschel to be presented to media
8. Minimally invasive heart surgery research wins NIH award
9. A step toward tissue-engineered heart structures for children
10. Research explains link between cholesterol and heart disease
11. Eating competence may lower risk of heart disease
Post Your Comments:
Breaking Biology News(10 mins):Improving the odds 2The Academy of Natural Sciences and Temple Press revive rare natural history work in new book 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 6476 1NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 6476 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 6476 3AIDS research reveals a lack of family planning programs in Uganda 61959 1AIDS research reveals a lack of family planning programs in Uganda 61959 2Stable plaque or heart attack plaque 3F USC researcher builds new sensor to tell which is which 10869 1Stable plaque or heart attack plaque 3F USC researcher builds new sensor to tell which is which 10869 2
Other Biology News:HIV pays a price for invisibility 2NIH funds development of resistance-breaking insecticides to reduce malaria transmission 2NIH funds development of resistance-breaking insecticides to reduce malaria transmission 3Annual Michael & Susan Dell lectureship in child health 2
Breaking Biology Technology:Lyric Presents the Sounds of the Season 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 2Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 3Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 4
[0] Lyric Presents the Sounds of the Season[0] Super cool atom thermometer[0] AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology[0] Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A
Other Biology Technology:MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 4, 2009 2Peregrine Pharmaceuticals Reports Positive Data in Second Phase II Bavituximab Breast Cancer Trial 2Peregrine Pharmaceuticals Reports Positive Data in Second Phase II Bavituximab Breast Cancer Trial 3Peregrine Pharmaceuticals Reports Positive Data in Second Phase II Bavituximab Breast Cancer Trial 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |